Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
Identifieur interne : 000F46 ( PubMed/Corpus ); précédent : 000F45; suivant : 000F47Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
Auteurs : Sara C. Auld ; Anne G. Kasmar ; David W. Dowdy ; Barun Mathema ; Neel R. Gandhi ; Gavin J. Churchyard ; Roxana Rustomjee ; N Sarita ShahSource :
- The Journal of infectious diseases [ 1537-6613 ] ; 2017.
Abstract
High rates of tuberculosis transmission are driving the ongoing global tuberculosis epidemic, and there is a pressing need for research focused on understanding and, ultimately, halting transmission. The ongoing tuberculosis-human immunodeficiency virus (HIV) coepidemic and rising rates of drug-resistant tuberculosis in parts of the world add further urgency to this work. Success in this research will require a concerted, multidisciplinary effort on the part of tuberculosis scientists, clinicians, programs, and funders and must span the research spectrum from biomedical sciences to the social sciences, public health, epidemiology, cost-effectiveness analyses, and operations research. Heterogeneity of tuberculosis disease, both among individual patients and among communities, poses a substantial challenge to efforts to interrupt transmission. As such, it is likely that effective interventions to stop transmission will require a combination of approaches that will vary across different epidemiologic settings. This research roadmap summarizes key gaps in our current understanding of transmission, as laid out in the preceding articles in this series. We also hope that it will be a call to action for the global tuberculosis community to make a sustained commitment to tuberculosis transmission science. Halting transmission today is an essential step on the path to end tuberculosis tomorrow.
DOI: 10.1093/infdis/jix353
PubMed: 29112744
Links to Exploration step
pubmed:29112744Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?</title>
<author><name sortKey="Auld, Sara C" sort="Auld, Sara C" uniqKey="Auld S" first="Sara C" last="Auld">Sara C. Auld</name>
<affiliation><nlm:affiliation>School of Medicine and Rollins School of Public Health, Emory University.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kasmar, Anne G" sort="Kasmar, Anne G" uniqKey="Kasmar A" first="Anne G" last="Kasmar">Anne G. Kasmar</name>
<affiliation><nlm:affiliation>Bill and Melinda Gates Foundation, Seattle, Washington.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dowdy, David W" sort="Dowdy, David W" uniqKey="Dowdy D" first="David W" last="Dowdy">David W. Dowdy</name>
<affiliation><nlm:affiliation>Bloomberg School of Public Health, Johns Hopkins University, Baltimore.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mathema, Barun" sort="Mathema, Barun" uniqKey="Mathema B" first="Barun" last="Mathema">Barun Mathema</name>
<affiliation><nlm:affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gandhi, Neel R" sort="Gandhi, Neel R" uniqKey="Gandhi N" first="Neel R" last="Gandhi">Neel R. Gandhi</name>
<affiliation><nlm:affiliation>School of Medicine and Rollins School of Public Health, Emory University.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Churchyard, Gavin J" sort="Churchyard, Gavin J" uniqKey="Churchyard G" first="Gavin J" last="Churchyard">Gavin J. Churchyard</name>
<affiliation><nlm:affiliation>Aurum Institute and the School of Public Health, University of Witwatersrand.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rustomjee, Roxana" sort="Rustomjee, Roxana" uniqKey="Rustomjee R" first="Roxana" last="Rustomjee">Roxana Rustomjee</name>
<affiliation><nlm:affiliation>Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shah, N Sarita" sort="Shah, N Sarita" uniqKey="Shah N" first="N Sarita" last="Shah">N Sarita Shah</name>
<affiliation><nlm:affiliation>Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:29112744</idno>
<idno type="pmid">29112744</idno>
<idno type="doi">10.1093/infdis/jix353</idno>
<idno type="wicri:Area/PubMed/Corpus">000F46</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F46</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?</title>
<author><name sortKey="Auld, Sara C" sort="Auld, Sara C" uniqKey="Auld S" first="Sara C" last="Auld">Sara C. Auld</name>
<affiliation><nlm:affiliation>School of Medicine and Rollins School of Public Health, Emory University.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kasmar, Anne G" sort="Kasmar, Anne G" uniqKey="Kasmar A" first="Anne G" last="Kasmar">Anne G. Kasmar</name>
<affiliation><nlm:affiliation>Bill and Melinda Gates Foundation, Seattle, Washington.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dowdy, David W" sort="Dowdy, David W" uniqKey="Dowdy D" first="David W" last="Dowdy">David W. Dowdy</name>
<affiliation><nlm:affiliation>Bloomberg School of Public Health, Johns Hopkins University, Baltimore.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mathema, Barun" sort="Mathema, Barun" uniqKey="Mathema B" first="Barun" last="Mathema">Barun Mathema</name>
<affiliation><nlm:affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gandhi, Neel R" sort="Gandhi, Neel R" uniqKey="Gandhi N" first="Neel R" last="Gandhi">Neel R. Gandhi</name>
<affiliation><nlm:affiliation>School of Medicine and Rollins School of Public Health, Emory University.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Churchyard, Gavin J" sort="Churchyard, Gavin J" uniqKey="Churchyard G" first="Gavin J" last="Churchyard">Gavin J. Churchyard</name>
<affiliation><nlm:affiliation>Aurum Institute and the School of Public Health, University of Witwatersrand.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rustomjee, Roxana" sort="Rustomjee, Roxana" uniqKey="Rustomjee R" first="Roxana" last="Rustomjee">Roxana Rustomjee</name>
<affiliation><nlm:affiliation>Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shah, N Sarita" sort="Shah, N Sarita" uniqKey="Shah N" first="N Sarita" last="Shah">N Sarita Shah</name>
<affiliation><nlm:affiliation>Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of infectious diseases</title>
<idno type="eISSN">1537-6613</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">High rates of tuberculosis transmission are driving the ongoing global tuberculosis epidemic, and there is a pressing need for research focused on understanding and, ultimately, halting transmission. The ongoing tuberculosis-human immunodeficiency virus (HIV) coepidemic and rising rates of drug-resistant tuberculosis in parts of the world add further urgency to this work. Success in this research will require a concerted, multidisciplinary effort on the part of tuberculosis scientists, clinicians, programs, and funders and must span the research spectrum from biomedical sciences to the social sciences, public health, epidemiology, cost-effectiveness analyses, and operations research. Heterogeneity of tuberculosis disease, both among individual patients and among communities, poses a substantial challenge to efforts to interrupt transmission. As such, it is likely that effective interventions to stop transmission will require a combination of approaches that will vary across different epidemiologic settings. This research roadmap summarizes key gaps in our current understanding of transmission, as laid out in the preceding articles in this series. We also hope that it will be a call to action for the global tuberculosis community to make a sustained commitment to tuberculosis transmission science. Halting transmission today is an essential step on the path to end tuberculosis tomorrow.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">29112744</PMID>
<DateCreated><Year>2017</Year>
<Month>11</Month>
<Day>07</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>11</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>216</Volume>
<Issue>suppl_6</Issue>
<PubDate><Year>2017</Year>
<Month>Nov</Month>
<Day>03</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of infectious diseases</Title>
<ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?</ArticleTitle>
<Pagination><MedlinePgn>S662-S668</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jix353</ELocationID>
<Abstract><AbstractText>High rates of tuberculosis transmission are driving the ongoing global tuberculosis epidemic, and there is a pressing need for research focused on understanding and, ultimately, halting transmission. The ongoing tuberculosis-human immunodeficiency virus (HIV) coepidemic and rising rates of drug-resistant tuberculosis in parts of the world add further urgency to this work. Success in this research will require a concerted, multidisciplinary effort on the part of tuberculosis scientists, clinicians, programs, and funders and must span the research spectrum from biomedical sciences to the social sciences, public health, epidemiology, cost-effectiveness analyses, and operations research. Heterogeneity of tuberculosis disease, both among individual patients and among communities, poses a substantial challenge to efforts to interrupt transmission. As such, it is likely that effective interventions to stop transmission will require a combination of approaches that will vary across different epidemiologic settings. This research roadmap summarizes key gaps in our current understanding of transmission, as laid out in the preceding articles in this series. We also hope that it will be a call to action for the global tuberculosis community to make a sustained commitment to tuberculosis transmission science. Halting transmission today is an essential step on the path to end tuberculosis tomorrow.</AbstractText>
<CopyrightInformation>© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Auld</LastName>
<ForeName>Sara C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo><Affiliation>School of Medicine and Rollins School of Public Health, Emory University.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kasmar</LastName>
<ForeName>Anne G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo><Affiliation>Bill and Melinda Gates Foundation, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dowdy</LastName>
<ForeName>David W</ForeName>
<Initials>DW</Initials>
<AffiliationInfo><Affiliation>Bloomberg School of Public Health, Johns Hopkins University, Baltimore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mathema</LastName>
<ForeName>Barun</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gandhi</LastName>
<ForeName>Neel R</ForeName>
<Initials>NR</Initials>
<AffiliationInfo><Affiliation>School of Medicine and Rollins School of Public Health, Emory University.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Churchyard</LastName>
<ForeName>Gavin J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo><Affiliation>Aurum Institute and the School of Public Health, University of Witwatersrand.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Advancing Care for tuberculosis and HIV, South African Medical Research Council, Johannesburg, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rustomjee</LastName>
<ForeName>Roxana</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shah</LastName>
<ForeName>N Sarita</ForeName>
<Initials>NS</Initials>
<AffiliationInfo><Affiliation>Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Infect Dis</MedlineTA>
<NlmUniqueID>0413675</NlmUniqueID>
<ISSNLinking>0022-1899</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">public health</Keyword>
<Keyword MajorTopicYN="N">transmission</Keyword>
<Keyword MajorTopicYN="N">tuberculosis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>11</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>11</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>11</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29112744</ArticleId>
<ArticleId IdType="pii">4589579</ArticleId>
<ArticleId IdType="doi">10.1093/infdis/jix353</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F46 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000F46 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaSubSaharaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:29112744 |texte= Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:29112744" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SidaSubSaharaV1
This area was generated with Dilib version V0.6.32. |